AR079294A1 - Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos - Google Patents
Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismosInfo
- Publication number
- AR079294A1 AR079294A1 ARP100104234A ARP100104234A AR079294A1 AR 079294 A1 AR079294 A1 AR 079294A1 AR P100104234 A ARP100104234 A AR P100104234A AR P100104234 A ARP100104234 A AR P100104234A AR 079294 A1 AR079294 A1 AR 079294A1
- Authority
- AR
- Argentina
- Prior art keywords
- iodine
- optionally
- group
- alkyl
- compound
- Prior art date
Links
- 229910052740 iodine Inorganic materials 0.000 title abstract 3
- 239000011630 iodine Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000004220 glutamic acid Substances 0.000 title 1
- 150000002307 glutamic acids Chemical class 0.000 title 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004043 oxo group Chemical group O=* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 101100079984 Caenorhabditis elegans nhr-9 gene Proteins 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- -1 inorganic acid salt Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Reivindicacion 1: Un compuesto caracterizado porque tiene la formula general (1) en donde n = 0 o 1; A se selecciona entre el grupo que comprende (2) y (3) donde * indica el átomo de conexion de A; R2 y R3 son hidrogeno, R1 es X donde X es Yodo-aril-G-CH2, donde G es un enlace directo o C1-5 alquilo donde un grupo metileno de la cadena alquilo puede reemplazarse opcionalmente por un átomo de oxígeno o por un átomo de nitrogeno y donde un grupo metileno puede estar sustituido con un grupo oxo (=O) y donde la unidad arilo está opcionalmente sustituida con 1 o 2 sustituyentes seleccionados en forma independiente entre R9, OH, OR9, NH2, NHR9, NR9R9 donde R9 es C1-3-alquilo, preferiblemente metilo; Yodo-heteroaril-G-CH2, donde G es un enlace directo o C1-5 alquilo, donde un grupo metileno de la cadena alquilo puede reemplazarse opcionalmente por un átomo de oxígeno o por un átomo de nitrogeno y donde un grupo metileno puede estar sustituido con un grupo oxo (=O) y donde heteroarilo comprende 5 a 6 átomos del anillo donde 1 o 2 átomos se seleccionan en forma independiente entre N, O o S y donde la unidad heteroarilo está opcionalmente sustituida con un grupo metilo o Yodo-CH=CH- (CH2)m, donde m = 1-3 incluyendo los isomeros, diastereomeros, tautomeros, isomeros E y Z y enantiomeros aislados, mezclas de los mismos, y sales adecuadas de los mismos. Reivindicacion 8: Un método para obtener compuestos de formula (I), (II) o mezclas de los mismos de acuerdo con las reivindicaciones 1 a 4 caracterizado porque comprende los siguientes pasos - hacer reaccionar un compuesto de formula general (III) con una unidad que contiene yodo donde el yodo es 123I, 124I, 125I, 127I, o 131I, - opcionalmente desproteger compuesto de formula (II) y - opcionalmente convertir el compuesto obtenido en una sal de ácidos orgánicos o inorgánicos adecuada del mismo, hidratos, complejos y solvatos del mismo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09075506 | 2009-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR079294A1 true AR079294A1 (es) | 2012-01-18 |
Family
ID=43661937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100104234A AR079294A1 (es) | 2009-11-17 | 2010-11-17 | Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130034497A1 (es) |
| EP (1) | EP2501416A1 (es) |
| JP (1) | JP2013510894A (es) |
| KR (1) | KR20120101073A (es) |
| CN (1) | CN102711841A (es) |
| AR (1) | AR079294A1 (es) |
| CA (1) | CA2780840A1 (es) |
| TW (1) | TW201124161A (es) |
| WO (1) | WO2011061154A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2520556A1 (en) * | 2011-05-03 | 2012-11-07 | Bayer Pharma Aktiengesellschaft | Radiolabeled amino acids for diagnostic imaging |
| US8784774B2 (en) | 2011-09-16 | 2014-07-22 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US8927732B2 (en) * | 2012-03-30 | 2015-01-06 | General Electric Company | Biotin stannane for HPLC-free radioiodination |
| US9468692B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US9468693B2 (en) | 2014-01-23 | 2016-10-18 | General Electric Company | Labeled molecular imaging agents and methods of use |
| US10373838B2 (en) * | 2015-12-08 | 2019-08-06 | Elemental Scientific, Inc. | Automatic sampling of hot phosphoric acid for the determination of chemical element concentrations and control of semiconductor processes |
| JP6848015B2 (ja) * | 2018-07-17 | 2021-03-24 | コリア アトミック エナジー リサーチ インスティテュートＫｏｒｅａ Ａｔｏｍｉｃ Ｅｎｅｒｇｙ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ | 放射性元素の標識方法、放射性標識化合物、及びそれを含む放射性元素標識キット |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9324872D0 (en) * | 1993-12-03 | 1994-01-19 | Univ Pasteur | Pharmaceutical compounds |
| WO2002014261A2 (en) * | 2000-08-10 | 2002-02-21 | Eli Lilly And Company | 4-substituted d-glutamic acid derivatives for use as antibiotic |
| EP1314041A2 (en) * | 2000-09-01 | 2003-05-28 | Annovis, Inc. | Screen for glutamate reuptake inhibitors, stimulators, and modulators |
| EP1732864B1 (en) * | 2004-03-18 | 2013-12-25 | Suntory Holdings Limited | Radiolabeled 3-[3- (benzoyl-amido) benzyloxy]aspartic acid derivative and method of producing the same |
| WO2007060012A2 (en) * | 2005-11-25 | 2007-05-31 | Samuel Samnick | Use of l-phenylalanine conjugated to an emitting isotope for therapy of hormone dependent carcinoma |
| ES2701423T3 (es) * | 2006-11-01 | 2019-02-22 | Life Molecular Imaging Sa | Acido L-glutámico marcado con [F-18], L-glutamina marcada con [F-18], sus derivados y su utilización, así como procedimientos para su preparación |
| US7893286B2 (en) | 2007-06-01 | 2011-02-22 | Cellectar, Inc. | Method for the synthesis of phospholipid ethers |
-
2010
- 2010-11-15 KR KR1020127015544A patent/KR20120101073A/ko not_active Application Discontinuation
- 2010-11-15 EP EP10781659A patent/EP2501416A1/en not_active Withdrawn
- 2010-11-15 JP JP2012539291A patent/JP2013510894A/ja active Pending
- 2010-11-15 US US13/510,359 patent/US20130034497A1/en not_active Abandoned
- 2010-11-15 CN CN2010800616418A patent/CN102711841A/zh active Pending
- 2010-11-15 CA CA2780840A patent/CA2780840A1/en not_active Abandoned
- 2010-11-15 WO PCT/EP2010/067500 patent/WO2011061154A1/en active Application Filing
- 2010-11-17 TW TW099139591A patent/TW201124161A/zh unknown
- 2010-11-17 AR ARP100104234A patent/AR079294A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20120101073A (ko) | 2012-09-12 |
| WO2011061154A1 (en) | 2011-05-26 |
| CN102711841A (zh) | 2012-10-03 |
| CA2780840A1 (en) | 2011-05-26 |
| TW201124161A (en) | 2011-07-16 |
| EP2501416A1 (en) | 2012-09-26 |
| US20130034497A1 (en) | 2013-02-07 |
| JP2013510894A (ja) | 2013-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR079294A1 (es) | Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos | |
| CO6290658A2 (es) | Derivados de azetidina y ciclobutano como inhibidores de jack | |
| PE20130375A1 (es) | Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos | |
| PE20091834A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona tiofenilo-sustituida como inhibidores de bace-1 y composiciones que los contienen | |
| CO6450621A2 (es) | Sulfonamidas nematocidas | |
| ECSP066966A (es) | Compuestos de aril-o heteroarilamida ortosustituidos | |
| PE20060570A1 (es) | Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10 | |
| PE20070321A1 (es) | Compuestos heterociclicos como inhibidores de proteasas | |
| ECSP066968A (es) | Compuestos de metil-aril o heteroaril-amida sustituida | |
| AR049401A1 (es) | Aza-biciclononanos | |
| UY31388A1 (es) | Método para la producción de 2´-desoxi-5-azacitidina (decitabina) | |
| PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
| AR052458A1 (es) | Amino-imidazolonas para la inhibicion de beta-secretasa | |
| UY28823A1 (es) | Compuestos de ácido alfa aril o heteroaril metil beta piperidino propanoico como antagonistas del receptor orl1 | |
| AR058546A1 (es) | Derivados de 2- adamantilurea como inhibidores selectivos de 11 beta - hsd1 | |
| AR052866A1 (es) | Fenil-metanonas monociclicas sustituidas | |
| PA8812801A1 (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicación en terapéutica | |
| AR048875A1 (es) | Un proceso para preparar montelukast y compuestos intermedios para el mismo | |
| PE20061490A1 (es) | Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1 | |
| CL2008002654A1 (es) | Compuestos derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, bloqueadores de los canales hcn; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cardiopatias isquemicas, insuficiencias cardiacas tanto sistolicas como diastolicas, entre otras. | |
| CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
| PE20191103A1 (es) | Inhibidores de dopamina-b-hidroxilasa | |
| CO6251363A2 (es) | Derivados de indol-2-ona disustituidos en 3 su preparacion y su aplicacion en terapeutica | |
| PE20090548A1 (es) | Compuestos aza-biciclohexano como inhibidores de trombina | |
| CO6241116A2 (es) | Pirimidil piperazinas utiles como ligandos del receptor d3/d2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |